Is There Hope for Oracle After Plummeting 35% This Year? ‘Yes’ Says One Analyst Predicting 210% Gains From Here
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Oracle (NYSE:ORCL | ORCL Price Prediction) is priced at $128.40, while Wall Street’s average price target sits at $235.77. That gap implies 83.6% upside.
Oracle has turned its database franchise into one of the most aggressive AI cloud buildouts in tech. Oracle Cloud Infrastructure revenue grew 121% last quarter. The biggest bull is Guggenheim Securities, whose Street-high $400.00 target implies roughly 211.5% upside.
Oracle’s backlog and its cash flow statement point in opposite directions, explaining the gap. The stock’s direction depends on which one wins.
Oracle’s AI Building Spree Became a Cash Burn Problem
Negative free cash flow drove this selloff. Oracle posted free cash flow of -$23.686 billion for fiscal 2026 on $55.663 billion of capex. Last quarter added another -$5.396 billion, and management expects full-year capex of $90 billion to $95 billion.
Funding that expansion means dilution and debt. Oracle earlier flagged raising about $40 billion this fiscal year, recently priced $20 billion of common stock and senior notes, and saw interest expense climb 55% to $1.4 billion. Fears about its ties to OpenAI added pressure.
Shares are down 33.25% year to date and 44.9% over a year. The slide began when a 4.99% revenue miss in the fiscal second quarter of 2026 sent shares down about 13%.
A $664 Billion Backlog Keeps Wall Street Bullish
Analysts are focused on remaining performance obligations (RPO), meaning revenue already under contract but not yet recognized. RPO reached $664 billion, up $209 billion year over year, with more than $30 billion in new AI contracts in one quarter. On the earnings call, CFO Hilary Maxson said, “We now expect around half of our RPO to convert into sales over the next 36 months.”
Ratings remain skewed, with 7 at Strong Buy, 28 at Buy, 7 at Hold and 1 at Sell. Guggenheim reaffirmed its Buy in late October, saying the market misprices contracted cash flow that should arrive as data centers shift from expansion to full use. Other desks have trimmed. Mizuho cut its target to $320.00, and Bernstein holds at $325.00.
Estimates are still rising. Consensus fiscal 2028 EPS moved from $10.8902 to $11.0636 over 90 days, against $8.1518 for fiscal 2027. Management guides fiscal 2027 revenue of at least $90 billion. GPU utilization hit 97.9%, and renewals priced at a 20% premium.
The weak spot: management gave no timeline for positive free cash flow. The upcoming fiscal second-quarter report, guided for 30-34% revenue growth, is the next test.
Microsoft and Amazon Rallied While Oracle Fell Alone
This selloff hit Oracle alone. Its hyperscale rivals are higher for the year.
Microsoft (NASDAQ:MSFT) trades at $521.13, up 8.44% year to date despite a 6.24% slip over the past week. Its $636.12 target implies 22.1% upside, with 12 at Strong Buy, 40 at Buy, 5 at Hold and zero Sell ratings. Azure grew 48%.
Amazon (NASDAQ:AMZN) trades at $266.17, up 15.31% year to date. Its $326.99 target implies 22.9% upside, backed by 16 at Strong Buy, 42 at Buy and 2 at Hold ratings. AWS grew 39%.
Oracle carries by far the largest analyst-implied upside in the group. Targets are estimates, though, and Oracle’s wider gap reflects its weaker balance sheet as much as opportunity.
Oracle Trades at 15x Forward Earnings After a 33% Slide
At $128.40, Oracle has 83.6% implied upside to the $235.77 consensus target set by 43 analysts. Shares are down 33.25% year to date, while the S&P 500 is up 11.41%.
The stock trades at roughly 15x forward earnings, inside a 52-week range of $109.21 to $248.46. Buyers are stirring: shares gained 8.83% last session and 3.77% over the past week.
Oracle’s Backlog Could Pay Off, If Cash Flow Turns
This bullish thesis works if RPO converts on management’s 36-month schedule and capex tops out this fiscal year, letting projects deliver the roughly 100% post-tax EBITDA cash conversion Maxson described. That path supports the consensus target well before Guggenheim’s $400 call.
Downside risks mount if more financing rounds keep diluting holders, data center delays push revenue out, or a major AI customer stumbles. Heavy leverage amplifies each of those risks.
Analyst view leans bullish. At about 15x forward earnings with a contracted backlog this large, the market is pricing in heavy execution risk. Keep an eye on free cash flow in each earnings report, since that metric decides whether this is a bargain or a value trap.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
